Colleen L. Channick

Papers

Total Citations

H-Index

About

Colleen L. Channick is a leading interventional pulmonologist whose work is redefining the diagnosis and treatment of complex thoracic diseases. Her research centers on advancing minimally invasive techniques for lung cancer care, with a particular focus on improving tissue acquisition for molecular testing. In her landmark 2022 study, "Novel Robotic-Assisted Cryobiopsy for Peripheral Pulmonary Lesions," Dr. Channick demonstrated how robotic bronchoscopy combined with cryobiopsy can obtain larger, higher-quality tissue samples—a critical advancement given that insufficient tumor cells often cause molecular testing failure. This work, which has garnered 80 citations, directly addresses a key bottleneck in personalized lung cancer therapy. Her broader contributions, outlined in her 2023 review "Interventional Pulmonology: Extending the Breadth of Thoracic Care," highlight how these techniques are replacing more invasive surgical options. By pushing the boundaries of what is possible through a bronchoscope, Dr. Channick is not only improving diagnostic yield but also expanding the therapeutic reach of interventional pulmonology, offering patients safer, more effective pathways to diagnosis and treatment.